These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3278832)

  • 1. Lovastatin: a new cholesterol-lowering agent.
    McKenney JM
    Clin Pharm; 1988 Jan; 7(1):21-36. PubMed ID: 3278832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pravastatin: a new drug for the treatment of hypercholesterolemia.
    Jungnickel PW; Cantral KA; Maloley PA
    Clin Pharm; 1992 Aug; 11(8):677-89. PubMed ID: 1511541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
    Illingworth DR; Bacon S
    Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
    Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA
    Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of lovastatin in primary hypercholesterolemia].
    Nakandakare ER; Garcia RC; Carré JM; Zerbinatti CV; Oliveira HC; Quintão EC
    Arq Bras Cardiol; 1989 May; 52(5):291-5. PubMed ID: 2690785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects.
    Agrawal AR; Tandon M; Sharma PL
    Int J Clin Pract; 2007 Nov; 61(11):1812-8. PubMed ID: 17935545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
    Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmarketing analysis of lovastatin use in the VA Northern California System of Clinics: a retrospective, computer-based study.
    Swislocki AL; Lin K; Cogburn D; Fann KY; Khuu DT; Noth RH
    Am J Manag Care; 1997 Oct; 3(10):1537-45. PubMed ID: 10178460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin 5-year safety and efficacy study. Lovastatin Study Groups I through IV.
    Arch Intern Med; 1993 May; 153(9):1079-87. PubMed ID: 8481075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Personal experience with lovastatin, a HMG-CoA reductase inhibitor (Mevacor, MSD) in the treatment of hypercholesterolemia].
    Vaverková H; Skottová N; Pudilová L; Horcicka V; Jezdinský J; Trtková M
    Vnitr Lek; 1991 May; 37(5):463-9. PubMed ID: 1842144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of clinical trials comparing HMG-CoA reductase inhibitors.
    Illingworth DR; Tobert JA
    Clin Ther; 1994; 16(3):366-85; discussion 365. PubMed ID: 7923304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic use of lovastatin in the treatment of hypercholesterolemia.
    Illingworth DR
    Clin Ther; 1994; 16(1):2-26; discussion 1. PubMed ID: 8205598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A
    Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin: a new cholesterol-lowering agent.
    Krukemyer JJ; Talbert RL
    Pharmacotherapy; 1987; 7(6):198-210. PubMed ID: 3328165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hyperlipidemia with HMG-CoA reductase inhibitors].
    Prager R
    Wien Med Wochenschr Suppl; 1989; 105():17-20. PubMed ID: 2694627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin. A preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidaemia.
    Henwood JM; Heel RC
    Drugs; 1988 Oct; 36(4):429-54. PubMed ID: 3069436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lovastatin for hypercholesterolemia.
    Zeller FP; Uvodich KC
    Drug Intell Clin Pharm; 1988; 22(7-8):542-5. PubMed ID: 3046888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.